Oxford COVID-19 vaccine data likely available in ‘weeks’

- Advertisement -

Data from trials of the COVID-19 vaccine being developed by a team from Oxford University in conjunction with pharmaceutical giant AstraZeneca might be available within weeks.

The news comes after US drugs company Pfizer announced that trials of its own COVID-19 vaccine, developed in partnership with Germany’s BioNTech, had returned an almost 90 percent success rate, clearing the way for licensing and distribution.

Experts said Pfizer’s announcement had raised hopes that dozens of other potential vaccines currently being trialled could soon return similar positive results.

READ  Bahrain: 676 new coronavirus cases from 10,075 tests


- Advertisement -